SEC Form 4 · accession 0001127430-17-000079

INSMED Inc · INSM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 5, 2017

Accepted (ET)

Sep 7, 2017 · 5:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001104506

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F2,F7	Sep 5, 2017	S	8,466	$29.00	D	267,262	D
Common Stock^F3	Sep 5, 2017	S	12,128	$28.69	D	255,134	D
Common Stock^F4	Sep 5, 2017	S	4,406	$29.35	D	250,728	D
Common Stock^F5	Sep 6, 2017	S	8,792	$26.07	D	241,936	D
Common Stock^F6	Sep 6, 2017	S	16,208	$25.71	D	225,728	D

No Table II lines on this filing.

F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.84 to $29.20, inclusive.
F3The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $28.82, inclusive.
F4The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.21 to $29.50, inclusive.
F5The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.89 to $26.40, inclusive.
F6The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.50 to $25.88, inclusive.
F7The number of shares reflected here excludes 443 shares previously reported for which Dr. Sharoky does not have beneficial ownership.